Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | BMY | AMGN | GILD | REGN |
| Company | Atara Biotherap | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6900 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 0.7001 | 48.57 | 266.06 | 66.72 | 920.73 |
| Low | 0.6800 | 48.12 | 260.68 | 66.16 | 891.67 |
| Last | 0.6954 | 48.57 | 266.67 | 66.39 | 891.97 |
| Change | +0.0037 | +0.27 | +3.92 | +0.23 | -2.02 |
| % Change | +0.53% | +0.56% | +1.49% | +0.35% | -0.23% |
| Volume | 382,479 | 2,448,101 | 770,638 | 2,435,753 | 158,507 |
| 20-Day Average Volume | 1,108,406 | 10,902,402 | 2,111,880 | 6,038,760 | 419,978 |
| Previous Close | 0.6917 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7126 | 50.83 | 272.37 | 69.88 | 934.95 |
| 20-Day Raw Stochastic | 34.54% | 12.46% | 15.56% | 5.21% | 2.05% |
| 20-Day Relative Strength | 47.80% | 38.52% | 39.54% | 28.82% | 32.95% |
| Weighted Alpha | -67.73 | -29.82 | +5.51 | -25.02 | +11.63 |
| Today's Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.12% since 04/12/24 | +0.39% since 04/12/24 | -0.85% since 04/12/24 | -2.58% since 04/12/24 | -1.38% since 04/12/24 |
| Low | 0.6500 on 04/15/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.7401 on 04/18/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | +1.49% since 03/19/24 | -6.43% since 03/19/24 | -2.47% since 03/19/24 | -9.66% since 03/19/24 | -7.41% since 03/19/24 |
| Low | 0.6194 on 03/26/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.8325 on 04/04/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +9.13% since 01/19/24 | -3.27% since 01/19/24 | -13.90% since 01/19/24 | -24.03% since 01/19/24 | -4.41% since 01/19/24 |
| Low | 0.5686 on 01/30/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.5800 on 02/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -49.78% since 10/19/23 | -14.18% since 10/19/23 | -5.55% since 10/19/23 | -15.46% since 10/19/23 | +10.33% since 10/19/23 |
| Low | 0.1986 on 11/13/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 1.5800 on 02/02/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,561 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 119,359 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 8,570,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -276,130,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 4,250,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -60,450,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.69 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 03/28/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |